Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06800937

Sphingolipidomic Profile in Anorexia Nervosa

Evaluation of the Sphingolipidomic Profile in Women Suffering From Anorexia Nervosa: Relationship With Clinical-endocrine and Psychiatric Parameters

Status
Recruiting
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Istituto Auxologico Italiano · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

: The objective of this research project will be to determine the sphingolipidomic profile in a group of women (\> 18 years) affected by Anorexia Nervosa (AN), phenotypically characterized (restricting \[AN-R\] vs binge-eating purging \[AN-BP\]). Specific questionnaires will be administered for the definition of the severity of the eating disorder and depressive state (suicidality), to which will be added the evaluation of gonadal function (i.e., plasma levels of estradiol/progesterone and use of oral contraceptives). Based on the specific lipidomic profile, which the present research project hopes to characterize, it will be possible to appropriately modify the diet of rehabilitation programs and, in the future, improve the effectiveness of the treatment itself, especially in the long term.

Conditions

Interventions

TypeNameDescription
OTHERDetermination of sphingolipidomic profileThe plasma/serum levels of the following sphingolipids will be measured: ceramides and dihydroceramides from C16 to C24, including 2 unsaturated ones (C18:1 and C24:1), sphingomyelins (those from C16 to C24 and the one C24:1), sphingosine, sphinganine, sphingosine-1-phosphate and sphinganine-1-phosphate.

Timeline

Start date
2024-06-19
Primary completion
2026-06-30
Completion
2026-06-30
First posted
2025-01-30
Last updated
2026-03-30

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06800937. Inclusion in this directory is not an endorsement.